The choice of formulation depends on the specific medication, the indication (diabetes or weight management), patient preference, and clinical suitability
The diagram rescales to that syringe, so the same dose sits at a different mark on a 0.3 mL barrel than on a U-100

GPX4: Glutathione Peroxidase 4, GSH: glutathione, ROS: reactive oxygen species, IL-6: Interleukin-6, Interleukin-1 beta, TNF-: Tumor Necrosis Factor-alpha, MDA: malondialdehyde, TCL6: T-cell Leukemia/Lymphoma 6,TFRC: transferrin receptor, ALKBH5: AlkB Homolog 5, RNA, demethylase, FTL: ferritin light chain, SLC7A11: Solute Carrier Family 7 Member 11, ACSL4: Acyl-CoA, Synthetase Long Chain Family Member 4, HUVECs: Human Umbilical Vein Endothelial Cells, BaP: Benzo[a]pyrene, MARCHF1: Membrane Associated Ring-CH-Type Finger 1, VEGFA: Vascular Endothelial Growth Factor A, ANG-1: Angiopoietin-1, IGF2BP3: Insulin-like Growth Factor 2 mRNA-binding Protein 3, lnc-HZ06: Long Non-coding RNA HZ06, HIF1: Hypoxia-inducible Factor 1-alpha, NCOA4: Nuclear Receptor Coactivator 4, CRY2: Cryptochrome Circadian Regulator 2, BMAL1: Brain and Muscle ARNT-Like 1, TP53: Tumor Protein p53, EZH2: Enhancer of Zeste Homolog 2, TIMP1: Tissue Inhibitor of Metalloproteinases 1, SLC3A2: Solute Carrier Family 3 Member 2, GABARAPL2: GABA, Type A Receptor-Associated Protein Like 2, Fer-1: ferrostatin-1

Patients should be reassured that gastrointestinal symptoms often improve with continued therapy as tolerance develops
Additionally, James Adjaye and Wasco Wruck acknowledge support from the Medical faculty of the Heinrich Heine University Dsseldorf
At this point in the therapy i have a large amount of scar tissue build up on the tendon, to the point of it being visible in the thickness of the tendon compared to the other elbow